Verona Pharma Plc Asset Turnover Ratio (VRNA), as of second quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Verona Pharma Plc  (NASDAQ: VRNA)
 

Verona Pharma Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Verona Pharma Plc asset turnover ratio, the ability of Verona Pharma Plc's assets to generate revenue in the second quarter 2025, increased sequentially to 0.42 in the second quarter (Jun 30 2025), yet the ratio remained below the average, as VRNA's position remain challenging.

Within sector 114 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2025 compared to the preceding quarter from 0 to 2764.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VRNA Asset Turnover Ratio (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Asset Change 32.34 % 81.9 % 56.95 % 30.21 % 42.43 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.42 0.24 0.1 0.01 -
VRNA's Total Ranking # 2764 # 0 # 0 # 0 # 0
Seq. Asset Change 9.2 % -19.78 % 71.71 % -12.02 % 50.09 %
Seq. Revenue Change 35.25 % 108.04 % 551.76 % - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 115
Healthcare Sector # 387
Overall Market # 2764

Asset Turnover Ratio Statistics
High Average Low
4.83 4.83 4.83
(Jun 30 2025)  




VRNA Company Profile • Back to VRNA Efficiency Comparisons • Compare VRNA Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2025 Assets at quarter ending Jun 30 2025
Cytomx Therapeutics Inc   1.06 $ 141.100  Millions$ 133.267  Millions
Sonoma Pharmaceuticals Inc   1.05 $ 14.912  Millions$ 14.178  Millions
Tactile Systems Technology Inc   1.05 $ 298.295  Millions$ 284.734  Millions
Avita Medical Inc   1.04 $ 74.884  Millions$ 72.113  Millions
Nrc Health  1.04 $ 140.315  Millions$ 135.225  Millions
Tela Bio Inc   1.04 $ 73.696  Millions$ 71.094  Millions
Sanara Medtech Inc   1.04 $ 96.228  Millions$ 92.946  Millions
Precision Optics Corporation Inc   1.03 $ 19.091  Millions$ 18.540  Millions
Axogen inc   1.02 $ 203.270  Millions$ 199.333  Millions
Treace Medical Concepts Inc   1.02 $ 213.751  Millions$ 210.577  Millions
Sbc Medical Group Holdings Incorporated  1.01 $ 294.794  Millions$ 290.617  Millions
Pacs Group Inc   1.01 $ 4,820.579  Millions$ 4,756.506  Millions
Nuwellis Inc   1.00 $ 8.240  Millions$ 8.200  Millions
Angiodynamics Inc   0.99 $ 290.645  Millions$ 294.215  Millions
Docgo Inc   0.98 $ 435.969  Millions$ 447.140  Millions
Lifeloc Technologies Inc   0.97 $ 8.494  Millions$ 8.728  Millions
Ensign Group Inc  0.97 $ 4,614.838  Millions$ 4,747.163  Millions
Strata Critical Medical Inc   0.97 $ 254.341  Millions$ 262.022  Millions
Adma Biologics Inc   0.97 $ 472.532  Millions$ 487.061  Millions
Accuray Incorporated  0.97 $ 457.967  Millions$ 474.059  Millions
Bionexus Gene Lab Corp   0.95 $ 9.552  Millions$ 10.083  Millions
Addus Homecare Corp  0.95 $ 1,274.240  Millions$ 1,345.513  Millions
Orthofix Medical Inc   0.95 $ 809.046  Millions$ 855.367  Millions
Cerus Corporation  0.94 $ 190.983  Millions$ 202.576  Millions
National Healthcare Corp  0.94 $ 1,458.155  Millions$ 1,549.544  Millions
Karyopharm Therapeutics Inc   0.94 $ 137.269  Millions$ 146.621  Millions
Milestone Scientific Inc   0.93 $ 8.888  Millions$ 9.528  Millions
Pediatrix Medical Group Inc   0.93 $ 1,940.725  Millions$ 2,081.288  Millions
Ufp Technologies Inc   0.92 $ 587.273  Millions$ 636.201  Millions
Evofem Biosciences Inc   0.92 $ 17.270  Millions$ 18.748  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.